Position in TGTX
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$27,470
+$10,860 QoQ
Shares Held
500
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#354
of 425 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TGTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026OAKWORTH CAPITAL, INC. holds $698,841 across 8 Biotechnology names. TGTX ranks #6 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
9,175 | $499,211 | |
| 2 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
124 | $61,594 | |
| 3 | CRSP |
CRISPR Therapeutics AG
|
646 | $35,232 | |
| 4 | MRNA |
Moderna, Inc.
|
500 | $35,015 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
56 | $34,917 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
This page
|
500 | $27,470 | |
| 7 | TECH |
BIO-TECHNE Corp
|
74 | $5,228 | |
| 8 | FTRE |
Fortrea Holdings Inc.
|
10 | $174 |
All Filings in TGTX
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,470 | 500 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $16,610 | 500 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $14,905 | 500 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $18,062 | 500 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $17,995 | 500 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $19,715 | 500 | Shares | Sole | 2025-04-24 | |
| 2024-12-31 | $15,050 | 500 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $11,695 | 500 | Shares | Sole | 2024-10-21 | |
| 2024-06-30 | $8,895 | 500 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $7,605 | 500 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $8,540 | 500 | Shares | Sole | 2024-01-31 | |
| No filing history on record for this holder in this stock. | ||||||